Abstract:OBJECTIVE:To investigate the effect of magnetic doxorubicin liposome (MDL) in the targeting treatment of nude mice bearing colon cancer.METHODS:Human colon cancer line LoVo cells were implanted hypodermically into nude mouse. Two weeks after the mouse was killed and the tumor was taken out and cut into small pieces to be retransplanted into nude mice so as to establish an experimental model. MDL was prepared by reverse-phase evaporation method. The particle size and structure of MDL were evaluated. Eighteen nude mice with colon cancer were divided into 3 groups of 3 mice: free DOX group, MDL (-) group (no magnetic field was added to the tumor surface), and MDL (+) group (magnetic field with the strength of 4,500 G was added). DOX of the dosage of 5 mg/kg was injected through the caudal vein in these 3 groups. Then the mice were killed 30 minutes after. Fluorescence spectrophotometry was used to examine the concentrations of DOX in the tissues and plasma. Another 36 nude mice with colon cancer were divided into 6 groups of 6 mice: normal saline group (as controls), DOX group, blank liposome group, magnetic liposome group, MDL (-) group (non-magnetic alloy was implanted into the tumor), and MDL (+) group (rare earth magnet was implanted into the tumor). The body weight, longest diameter of tumor, and short diameter vertical to the longest diameter were calculated regularly. The mice were killed 11 days after. The tumors were taken out to undergo staining and light microscopy. Flow cytometry was used to examine the apoptosis of tumor cells.RESULTS:The particle size of MDL was 230 nm and the magnetic particles (Fe(3)O(4)) were evenly distributed within the liposome. The DOX concentration in tumor tissue of the MDL (+) group was remarkably higher than those of the DOX and MDL (-) groups (both P < 0.05). The DOX concentration in heart and kidney of the DOX group were higher than those of the other 2 groups, and the plasma DOX concentrations of the DOX group was significantly lower than those of the other groups (all P < 0.05). The growth speed of tumor in the MDL (+) group was significantly lower, and the tumor weight was significantly less than in other groups.CONCLUSION:Magnetic doxorubicin liposome, as a carrier of anticancer drug, has a good targeting function toward the magnetite and has a significant anticancer effect.

Animal Experiment on Anti-Tumor Activity of Magnetic Nanocarrier and Doxorubicin with Target Simple External Magnetic Fields

Magnetic Field Activated Drug Release System Based on Magnetic PLGA Microspheres for Chemo-Thermal Therapy.

Study on Angiogenesis-Targeting Peptide Modified Iron Oxide Nanoparticles Used in Local Magnetic Hyperthermia in Tumor-Bearing Nude Mouse Models

Precision Treatment of Colon Cancer Using Doxorubicin-Loaded Metal-Organic-Framework-Coated Magnetic Nanoparticles

Study on the Application of Doxorubicin-Loaded Magnetic Nanodrugs in Targeted Therapy of Liver Cancer

[Targeting Therapy of Magnetic Doxorubicin Liposome in Nude Mice Bearing Colon Cancer].

External Magnetic Field-Enhanced Chemo-Photothermal Combination Tumor Therapy Via Iron Oxide Nanoparticles.

Co-Encapsulation of Magnetic Fe3o4 Nanoparticles and Doxorubicin into Biodegradable Plga Nanocarriers for Intratumoral Drug Delivery

Magnetically triggered drug release from nanoparticles and its applications in anti-tumor treatment

A novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapy.

Micelle-like Nanoparticles for Drug Delivery and Magnetically Enhanced Tumor Chemotherapy

Magnetic Liposomes for Light-Sensitive Drug Delivery and Combined Photothermal-Chemotherapy of Tumors

Magnetic Targeting and Ultrasound Activation of Liposome-Microbubble Conjugate for Enhanced Delivery of Anti-Cancer Therapies.

Preparation and Properties of Doxorubicin-loaded Magnetic Nanospheres

Enhanced Synergism of Thermo-chemotherapy For Liver Cancer with Magnetothermally Responsive Nanocarriers

Magnetite nanoparticles as smart carriers to manipulate the cytotoxicity of anticancer drugs: Magnetic control and pH-responsive release

Targeting Therapy of Magnetic Doxorubicin Stealth Liposome on Human Gastric Cancer Xenografts in Nude Mice

Magnetic delivery of Fe 3 O 4 @polydopamine nanoparticle-loaded natural killer cells suggest a promising anticancer treatment.

Dual Responsive Magnetic Drug Delivery Nanomicelles with Tumor Targeting for Enhanced Cancer Chemo/Magnetothermal Synergistic Therapy

Antitumor Effects of pH-/Reduction-Responsive Fe 3 O 4 @Alginate Magnetic Nanoparticles Loaded with Doxorubicin on Subcutaneous Tumor Models of Hepatocellular Carcinoma Xenografts in BALB/c Nude Mice

A Novel Magnetic Nanoparticle Hyperthermia Combined with Acmf-Dependant Drug Release by Damms Injection in Vx-2 Liver Tumors